The supplemental guidelines recommend endoscopic treatment with continuous warfarin therapy if the prothrombin time‐international normalized ratio is within the therapeutic range or a temporary change to DOAC for non‐valvular atrial fibrillation. Here, F2 is linked to atrial fibrillation.